Joann L. Data, M.D., Ph.D.

 
-Consultant in Drug Development and Regulatory Affairs

 
Education:
B.A. (1966) – Purdue University
M.D. (1970) – Washington University School of Medicine
Ph.D. (1977) – Vanderbilt University
Internship – State University of New York at Buffalo (Internal Medicine)
Fellowship - Vanderbilt University, Tennessee (Clinical Pharmacology)

Bio:
Joann Data is currently working as a drug development consultant for several biopharmaceutical companies and universities.  She retired from Amylin Pharmaceuticals, Inc. where she held several senior management positions that include Senior Vice President of Corporate Assignments (June 2005-December 2005) and Senior Vice President of Regulatory Affairs and Quality Assurance (August 1999 to June 2005).  While at Amylin, she provided regulatory and clinical consulting services to Cortex Pharmaceuticals, Inc. as Senior Vice President of Clinical Development and Regulatory Affairs in 2002 -2003, and to Allergan Phar­maceutics from 2003-2005.  She served on the Board of Directors of Nvnta Biopharmaceuticals Corporation from 2001 – 2008.

Data previously served as Executive Vice President of Product Development and Regulatory Affairs for CoCensys Inc. Her experience also includes several positions at the Upjohn Company, including Corporate Vice President for Worldwide Pharmaceutical Regulatory Affairs and Project Management, and a number of positions at Hoffmann-La Roche, including Vice President of Clinical Research and Development.  Data has been an adjunct assistant professor in medicine and pharmacology at Duke University Medical Center and at Weill Cornell Medical Center.   Data held an instructorship in medicine and pharmacology at Vanderbilt University before beginning her pharmaceutical career.

Data is a member of several medical societies including the American Society for Clinical Pharmacology of which she was President in 1994.  She serves on the editorial boards of the Journal of Pharmaceutical Medicine and the Journal of Clinical Pharmacology and Therapeutics.  Data has authored numerous peer-reviewed scientific publications.  She recently completed a book chapter for Principles of Clinical and Translational Research.  She has been elected to Who’s Who in American Women and received The Henry W. Elliott Distinguished Service Award from the American Society for Clinical Pharmacology and Therapeutics in 2003